|
Re: Video presentation from August 25, 2021
|
7
|
Resverlogix Corp.
|
Aug 31, 2021 11:22AM
|
|
Re: Vas. Dementia pipeline RVX?
|
4
|
Resverlogix Corp.
|
Dec 06, 2022 05:23PM
|
|
Re: Vas. Dementia pipeline RVX?
|
4
|
Resverlogix Corp.
|
Dec 07, 2022 11:24AM
|
|
Re: Updated List of BET inhibitors
|
3
|
Zenith Epigenetics
|
Apr 12, 2019 03:02PM
|
|
Re: Update from IR -- Eversana paused?
|
5
|
Resverlogix Corp.
|
Dec 22, 2022 10:11AM
|
|
Re: Update
|
1
|
Resverlogix Corp.
|
Feb 16, 2018 12:30PM
|
|
Re: Update
|
4
|
Resverlogix Corp.
|
Jul 12, 2017 02:59PM
|
|
Re: Update
|
2
|
Zenith Epigenetics
|
Jul 15, 2017 12:40PM
|
|
Re: Update
|
6
|
Resverlogix Corp.
|
Dec 17, 2021 12:28PM
|
|
Re: Upcoming RVX presentations, human blood microarray & babbling on FACET analysis
|
2
|
Resverlogix Corp.
|
Jul 24, 2015 05:38PM
|
|
Re: Underwhelmed
|
1
|
Resverlogix Corp.
|
Aug 30, 2017 08:51AM
|
|
Re: two things most believe
|
|
Resverlogix Corp.
|
Sep 08, 2021 06:11PM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
6
|
Zenith Epigenetics
|
Sep 05, 2018 03:50PM
|
|
Re: Two investor conferences May 2
|
4
|
Resverlogix Corp.
|
May 01, 2016 03:39PM
|
|
Re: Two articles - Apabetalone for Colon Cancer?
|
4
|
Resverlogix Corp.
|
Jul 09, 2021 10:50AM
|
|
Re: TSX Review
|
3
|
Resverlogix Corp.
|
Mar 15, 2018 01:18PM
|
|
Re: TSX Review
|
2
|
Resverlogix Corp.
|
Mar 13, 2018 09:02PM
|
|
Re: trying to making sense
|
7
|
Resverlogix Corp.
|
Mar 09, 2022 11:55AM
|
|
Re: Trillium
|
2
|
Zenith Epigenetics
|
Aug 26, 2021 07:18PM
|
|
Re: Trillium
|
5
|
Zenith Epigenetics
|
Aug 25, 2021 11:20AM
|
